Demonstrates concurrent estimation of cefixime and ornidazole, indicating environmental sustainability benefits.
Design of experiments has emerged as an influential and proactive approach that demonstrated favored applicability in optimizing chromatographic procedures. Quality-by-design guarantees the long-standing efficiency of the developed HPLC method reducing the need for costly and resource-intensive univariate approach. A low environmental footprint, sensitive, fast, and simple HPLC method was developed for concurrent estimation of cefixime (CFX) and ornidazole (ORN) in their raw materials, laboratory-prepared tablets, and pharmaceutical formulations using 2 3 full factorial design. The separation was performed on a cyano column through UV detection at 300 nm in less than 4 min. The elution was achieved using a mobile phase (pH = 6.0) composed of methanol and 0.3% triethylamine in ratio of (85%: 15%, v/v), respectively with a flow rate of 1 mL/min. The method’s validity was established with ICH \:Q₂R₁ regulations. Excellent linear correlation ( r = 0.9999) was established within concentration ranges lies between 1 and 50 µg/mL and 0.5–50 µg/mL with high percent found of 100.04 ± 0.82 and 99.99 ± 1.01 for CFX and ORN, respectively. The approach exhibited high precision (% RDS < 2) and sensitivity with detection limits of 0.07 and 0.09 µg/mL and quantification limits of 0.21 and 0.28 µg/mL for CFX and ORN, respectively. Several metrics evidenced the method’s greenness and sustainability profile.
No takes yet. Share an insight, caveat, or question.
Mostafa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: